December 07, 2017

Adoptive T cell immunotherapy describes the ex-vivo enhancement of a patient’s T cells to combat cancer. In order to evaluate new adoptive T cell immunotherapies, sensitive in vitro cytotoxicity assays that include kinetic imaging and cellular analysis of 3D target cell models are required.

T Cell-Mediated Cytotoxicity

link